A recent study carried out by Fancello and colleagues has found that, in approximately 34% of invasive breast cancer samples, ribosomal alterations were driven by mutations in the uL18/RPL5 ribosomal protein genes, thus highlighting the suppressor role of RPL5 in breast cancer (168). This evidence concerns the gene RPL5 and breast carcinoma.